Golden Star Promotes Its Vapor Spirit Utilizing Coattail Marketing Strategies at Trade Shows

NEW YORK, Nov. 24, 2014 (GLOBE NEWSWIRE) -- Golden Star Enterprises Ltd. (OTC Pink: GSPT) reports that the Company had a successful reception with its "Evolution of Alcohol Campaign" at the recent Taboo Tradeshows in both Calgary and Edmonton, Alberta, Canada with its vaporized alcohol product, Vapor Spirit.

The Company has been using Coattail Marketing strategies along with other alternative selling methods like Ambush or Tag Marketing to sell its Vapor Spirit product. It is more cost effective to promote Vapor Spirit products along with other simpatico products whereby potential customers in complimentary businesses can be found rather than to compete directly within the sector that you are in. A list of stores carrying Vapor Spirit can be found on the Company's website www.vaporspirit.net.

The Vapor Spirit advantage is that it requires less alcohol to feel the effects compared to drinking it which means your alcohol will go further than normal. Ingesting alcohol through your lungs will get it into your bloodstream faster and will affect you more quickly than ingesting alcohol through your stomach. The time it takes to sober up is diminished as well as there is only a small amount of alcohol in a shot, although it may take several shots for heavy drinkers to have the required effect.

Furthermore, it is very evident that Vaping is now here to stay since the Oxford Dictionary has announced that the new word for the year is VAPE.

About Vapor Spirit

Vapor Spirit is a new and unique way of consuming alcohol which allows drinkers to vaporize alcohol, reducing calories, hangovers, and enhancing flavor. It is not just a trend, it is arguably the evolution of drinking.

For more information on Vapor Spirit, visit www.vaporspirit.net.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained herein which are not historical fact are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays in testing and evaluation of products and other risks detailed from time to time in Golden Star's filings with OTC Markets.